We have just gotten word that the US Senate has passed the Atrial Fibrillation Resolution (S. Res. 243) by unanimous consent. The resolution, introduced by Sen. Crapo and co-introducers Sen. Casey, Sen. Inouye, Sen. Akaka, Sen. Rubio, and Sen. Toomey, promotes increased awareness, diagnosis, and treatment of atrial fibrillation. More information as it is available.
Read More
The US FDA has just announced that on September 8, 2011, the FDA Cardiovascular and Renal Drugs Advisory Committee will meet to review whether to recommend approval of rivaroxaban (brand name Xarelto), an alternative to warfarin, for stroke prevention in atrial fibrillation. In this recent video interview, Dr. Elaine Hylek, a leading anticoagulant authority, discussed …
Read More